A quality improvement initiative to improve rates of germline testing among men with prostate cancer through the use of an in-clinic educational session.
IMPRINT: A Pilot Study to Improve Germline Testing in At-Risk Patients With Prostate Cancer
This is a prospective single arm quality improvement initiative for the use of a standardized educational intervention on germline testing in prostate cancer to improve the rates of germline genetic testing among patients recommended for testing. Patients who consent to the study will undergo a one-on-one education session regarding the rationale and the benefits/risks of germline testing. Following the educational session, if a patient wishes to proceed with testing, they will sign the standard consent to proceed with germline testing via a commercial assay.